HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Does optical coherence tomography optimize results of stenting? Rationale and study design.

AbstractBACKGROUND:
To date, no randomized study has investigated the value of optical coherence tomography (OCT) in optimizing the results of coronary angioplasty for non-ST-segment elevation acute coronary syndromes.
METHODS:
DOCTORS is a randomized, prospective, multicenter, open-label clinical trial to evaluate the utility of OCT to optimize results of angioplasty of a lesion responsible for non-ST-elevation acute coronary syndromes. Patients (n = 250) will be randomized to undergo OCT-guided angioplasty (use of OCT to optimize procedural result, including change to strategy with the possibility of additional interventions) or angioplasty under fluoroscopy alone. The primary end point is the functional result of the angioplasty procedure as assessed by fractional flow reserve (FFR) measured at the end of the procedure. Secondary end points include safety of OCT in the context of angioplasty for ACS, percentage of patients in whom OCT reveals suboptimal result of stenting, percentage of patients in whom a change in procedural strategy is decided based on OCT data, correlation between quantitative measures by OCT and FFR, determination of a threshold for quantitative OCT measure that best predicts FFR ≥ 0.90, and identification of OCT variables that predict postprocedure FFR. Adverse cardiac events (death, recurrent myocardial infarction, stent thrombosis, and repeat target lesion revascularization) at 6 months will be recorded.
CONCLUSION:
The DOCTORS randomized trial (ClinicalTrials.gov NCT01743274) is designed to investigate whether use of OCT yields useful additional information beyond that obtained by angiography alone and, if so, whether this information changes physician strategy and impacts on the functional result of angioplasty as assessed by FFR.
AuthorsNicolas Meneveau, Fiona Ecarnot, Geraud Souteyrand, Pascal Motreff, Christophe Caussin, Eric Van Belle, Patrick Ohlmann, Olivier Morel, Alain Grentzinger, Michael Angioi, Romain Chopard, François Schiele
JournalAmerican heart journal (Am Heart J) Vol. 168 Issue 2 Pg. 175-81.e1-2 (Aug 2014) ISSN: 1097-6744 [Electronic] United States
PMID25066556 (Publication Type: Journal Article, Randomized Controlled Trial)
CopyrightCopyright © 2014 Mosby, Inc. All rights reserved.
Topics
  • Acute Coronary Syndrome (physiopathology, therapy)
  • Angioplasty, Balloon, Coronary
  • Fractional Flow Reserve, Myocardial
  • Humans
  • Research Design
  • Stents
  • Tomography, Optical Coherence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: